NCT04268147View on ClinicalTrials.gov

Instrumented Data Exchange for Ataxia Study

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

April 30, 2024

Study Completion Date

June 30, 2024

Conditions
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 6Friedreich Ataxia
Trial Locations (5)

21231

Johns Hopkins Medicine, Baltimore

60637

The University of Chicago, Chicago

90095

University of California-Los Angeles, Los Angeles

97239

Oregon Health & Science University, Portland

02114

Mass General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Biogen

INDUSTRY

collaborator

APDM Wearable Technologies

UNKNOWN

lead

University of Chicago

OTHER

NCT04268147 - Instrumented Data Exchange for Ataxia Study | Biotech Hunter | Biotech Hunter